ABOUT LUX
Lux Biosciences is a
clinical stage biotechnology company specializing in the development and
commercialization of innovative medications for serious ophthalmic diseases.
With a first-in-class product in NDA/MAA submission stage and several
exciting earlier-stage projects, Lux is building a revenue-generating,
high-growth, and sustainable ophthalmic company. |
||||
| © 2009 Lux Biosciences, Inc. All rights reserved. | Web Terms | Enlarged Text | Clinical Trials | |
![]()
![]()

